Literature DB >> 21555625

Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate.

Andrea D Birnbaum, Yi Jiang, Howard H Tessler, Debra A Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21555625     DOI： 10.1001/archophthalmol.2011.82

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  10 in total

1.  Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.

Authors:  Stacey Lu; Mehran Taban
Journal:  Digit J Ophthalmol       Date:  2016-06-28

2.  Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.

Authors:  John D Sheppard; Melissa M Toyos; John H Kempen; Paramjit Kaur; C Stephen Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

3.  Application of Ultra-Centrifugation and Bench-Top 19F NMR for Measuring Drug Phase Partitioning for the Ophthalmic Oil-in-Water Emulsion Products.

Authors:  Xinyi Wang; Sharadrao M Patil; David A Keire; Xiaoming Xu; Kang Chen
Journal:  AAPS PharmSciTech       Date:  2018-03-02       Impact factor: 3.246

4.  Risk of Elevated Intraocular Pressure With Difluprednate in Patients With Non-Infectious Uveitis.

Authors:  Mehmet Yakin; Aman Kumar; Shilpa Kodati; Leslie Jones; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

Review 5.  Medical management of uveitis - current trends.

Authors:  Kalpana Babu; Padmamalini Mahendradas
Journal:  Indian J Ophthalmol       Date:  2013-06       Impact factor: 1.848

6.  Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.

Authors:  T Borrás; L K Buie; M G Spiga
Journal:  Gene Ther       Date:  2016-02-08       Impact factor: 5.250

7.  A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%.

Authors:  Yael Kusne; Paul Kang; Robert E Fintelmann
Journal:  Clin Ophthalmol       Date:  2016-11-23

8.  Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis.

Authors:  Debra A Goldstein; Diana Do; Glenn Noronha; Jennifer M Kissner; Sunil K Srivastava; Quan D Nguyen
Journal:  Transl Vis Sci Technol       Date:  2016-12-14       Impact factor: 3.283

9.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020

10.  Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.

Authors:  Joanne Thomas; Sanjana Kuthyar; Jessica G Shantha; Sheila T Angeles-Han; Steven Yeh
Journal:  Ann Eye Sci       Date:  2021-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.